<img src="https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7?size=2" nborder="0" align="left" hspace="5" vspace="5" title="22157.jpg" alt="Company Logo"/>Key market opportunities include growing surgical procedure volumes, increased demand for bioactive materials, and expanding minimally invasive surgeries. The rise in accidents and chronic diseases fuels demand for effective hemostatic solutions like TachoSil. Potential growth in Asia-Pacific presents further opportunities.Dublin, May 11, 2026 <a href="https://www.globenewswire.com" target="_blank">(GLOBE NEWSWIRE)</a> -- The <a href="https://www.researchandmarkets.com/reports/6103951/tachosil-market-report-epidemiology-pipeline?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=bmcsnw&amp;utm_campaign=2248519+-+Tachosil+(Corza+Medical)+Market+Research+Report+2026%3a+Epidemiology%2c+Pipeline+Analysis%2c+Insights+%26+Forecasts%2c+2020-2025%2c+2025-2030F%2c+2035F&amp;utm_exec=chdomsai" rel="nofollow" target="_blank" title="Tachosil Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights &amp; Forecasts">"Tachosil Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights &amp; Forecasts"</a> has been added to ResearchAndMarkets.com's offering. The "Tachosil Market Global Report 2026" delivers crucial insights for strategists, marketers, and senior management, offering a comprehensive analysis of the tachosil market. This rapidly expanding market is set to be shaped by various trends over the next decade and beyond. TachoSil, primarily used in cardiovascular, orthopedic, general, transplant, and neurosurgery, is composed of a collagen matrix and fibrinogen, facilitating clot formation and hemostasis. Available in liquid and patch forms, it is distributed through various medical facilities, anchoring its place within the surgical supply market. The TachoSil market encompasses sales of surgical adhesion barriers and hemostatic agents, distributing these essential tools to meet growing demands globally. The market's value derives from revenues generated by entities selling goods or services in the defined geographical areas. The TachoSil market is experiencing significant growth driven by the increasing volumes of surgical procedures, adoption of collagen-based hemostatic products, expansion in transplant and cardiovascular surgeries, and the availability of advanced surgical materials. Clinical outcomes have been further enhanced with fibrin-based patches, leading to better post-surgical healing. Looking ahead, the TachoSil market is poised to expand further. This growth is supported by rising demand for bioactive surgical materials, higher investments in wound care solutions, and increased emphasis on surgical efficiency. Innovations in biodegradable hemostatic technologies and a growing preference for minimally invasive surgeries are shaping industry dynamics. Key trends include the adoption of advanced surgical hemostats, patch-based hemostatic solutions, and rapid bleeding control products. The uptick in surgical procedures significantly boosts the TachoSil market. Such procedures address chronic diseases, leverage advancements in medical technology, and fulfill the demand for minimally invasive treatments. As a critical component during surgeries, TachoSil aids in effective hemostasis and tissue sealing, reducing complications and enhancing outcomes. For instance, Intuitive Surgical, Inc.'s system usage soared from 2,286,000 procedures in 2023 to 2,683,000 in 2024, illustrating a positive trend supporting TachoSil's market. Accidents also play a role in TachoSil's market expansion. Rising vehicle usage, distracted driving, and inadequate road safety exacerbate accident rates. TachoSil's efficacy in controlling bleeding and aiding tissue sealing in traumatic interventions elevates its demand. Transport Canada's report on increasing road accident fatalities and injuries further underscores the necessity and growth of such hemostatic solutions. Corza Medical's acquisition of Takeda's TachoSil manufacturing operations in July 2024 exemplifies strategic market maneuvering. This acquisition aims to boost operational capabilities, streamline supply chains, and enhance customer services globally, fostering product introductions in Corza's biosurgery portfolio. Originated by Takeda, TachoSil's manufacturing shift signals consolidation aiming at market enhancement. Geographically, North America led the TachoSil market in 2025, with the Asia-Pacific region forecasted to grow rapidly. The market spans various continents, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, with countries like the USA, Canada, China, and Japan among the key players. Key Topics Covered: 1. Executive Summary 1.1. Key Market Insights (2020-2035) 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots 1.3. Major Factors Driving the Market 1.4. Top Three Trends Shaping the Market 2. Tachosil Market Characteristics 2.1. Market Definition &amp; Scope 2.2. Market Segmentations 2.3. Overview of Key Products and Services 2.4. Global Tachosil Market Attractiveness Scoring and Analysis 2.4.1. Overview of Market Attractiveness Framework 2.4.2. Quantitative Scoring Methodology 2.4.3. Factor-Wise Evaluation Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment and Risk Profile Evaluation 2.4.4. Market Attractiveness Scoring and Interpretation 2.4.5. Strategic Implications and Recommendations 3. Tachosil Market Supply Chain Analysis 3.1. Overview of the Supply Chain and Ecosystem 3.2. List of Key Raw Materials, Resources &amp; Suppliers 3.3. List of Major Distributors and Channel Partners 3.4. List of Major End Users 4. Global Tachosil Market Trends and Strategies 4.1. Key Technologies &amp; Future Trends 4.1.1 Biotechnology, Genomics &amp; Precision Medicine 4.1.2 Industry 4.0 &amp; Intelligent Manufacturing 4.1.3 Sustainability, Climate Tech &amp; Circular Economy 4.1.4 Digitalization, Cloud, Big Data &amp; Cybersecurity 4.1.5 Internet of Things (IoT), Smart Infrastructure &amp; Connected Ecosystems 4.2. Major Trends 4.2.1 Increasing Use of Advanced Surgical Hemostats 4.2.2 Rising Adoption of Patch-Based Hemostatic Solutions 4.2.3 Expansion of Minimally Invasive Surgical Procedures 4.2.4 Growing Demand for Rapid Bleeding Control Products 4.2.5 Enhanced Focus on Post-Surgical Healing Outcomes 5. Tachosil Market Analysis of End Use Industries 5.1 Hospitals 5.2 Specialty Surgical Clinics 5.3 Ambulatory Surgical Centers 5.4 Transplant Centers 5.5 Trauma Care Units 6. Tachosil Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War &amp; Trade Protectionism, and Covid and Recovery on the Market 7. Global Tachosil Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis 7.1. Global Tachosil PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints) 7.2. Global Tachosil Market Size, Comparisons and Growth Rate Analysis 7.3. Global Tachosil Historic Market Size and Growth, 2020-2025, Value ($ Billion) 7.4. Global Tachosil Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion) 8. Global Tachosil Total Addressable Market (TAM) Analysis for the Market 8.1. Definition and Scope of Total Addressable Market (TAM) 8.2. Methodology and Assumptions 8.3. Global Total Addressable Market (TAM) Estimation 8.4. TAM vs. Current Market Size Analysis 8.5. Strategic Insights and Growth Opportunities from TAM Analysis 9. Tachosil Market Segmentation 9.1. Global Tachosil Market, Segmentation by Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery, Neurosurgery 9.2. Global Tachosil Market, Segmentation by Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion Liquid Formulations, Patch Formulations 9.3. Global Tachosil Market, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion Hospitals, Specialty Clinics, Ambulatory Surgical Centers For more information about this report visit <a href="https://www.researchandmarkets.com/reports/6103951/tachosil-market-report-epidemiology-pipeline?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=bmcsnw&amp;utm_campaign=2248519+-+Tachosil+(Corza+Medical)+Market+Research+Report+2026%3a+Epidemiology%2c+Pipeline+Analysis%2c+Insights+%26+Forecasts%2c+2020-2025%2c+2025-2030F%2c+2035F&amp;utm_exec=chdomsai" rel="nofollow" target="_blank" title="">https://www.researchandmarkets.com/r/enonpl</a> About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. <pre>CONTACT: 
CONTACT: ResearchAndMarkets.com 
 Laura Wood,Senior Press Manager 
 press@researchandmarkets.com
 For E.S.T Office Hours Call 1-917-300-0470 
 For U.S./ CAN Toll Free Call 1-800-526-8630 
 For GMT Office Hours Call +353-1-416-8900 

</pre> <img alt="" src='https://ml.globenewswire.com/media/YTQ5NjAzZTAtYjI2ZS00MjU4LTgyMGYtOTA4ZDFiZmNkNzI5LTEwMjY3MzctMjAyNi0wNS0xMS1lbg==/tiny/Research-and-Markets.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Tachosil (Corza Medical) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn